Tokyo, Sept. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062819) titled 'The Relationship Between Patient Anxiety and Irradiation Position Deviation in Particle Therapy' on Sept. 7.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - National Research and Development Agency for Quantum Science and Technology
Condition:
Condition - Prostate Cancer, Liver Cancer, Lung Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to clarify the relationship between anxiety levels measured at different stages of the heavy-ion radiation therapy process-namely, at the time of providing informed consent for the study, before the CT scan for treatment planning, before the first treatment and before the final treatment-and setup errors during treatment.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients aged 18 years or over with prostate, lung or liver cancer, who are due to undergo gold marker implantation in preparation for heavy-ion beam therapy.
2. Individuals capable of completing psychological assessments.
3. Individuals from whom written informed consent can be obtained.
Key exclusion criteria - 1. Patients aged 18 or over with prostate, lung or liver cancer, who are due to have gold markers inserted in preparation for heavy-ion beam therapy.
2. Individuals capable of completing psychological assessments.
3. Individuals from whom written informed consent can be obtained.
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 10 Day
Date of IRB - 2026 Year 08 Month 10 Day
Anticipated trial start date - 2026 Year 10 Month 01 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071793
Disclaimer: Curated by HT Syndication.
